SAN FRANCISCO, Dec. 29, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC), a leading digital health care company focused on creating trusted solutions that detect, predict, and prevent disease, announced today that the company will be participating in the upcoming 44th Annual J.P. Morgan Healthcare Conference. iRhythm’s management is scheduled to present on Monday, January 12, 2026, at 8:15 a.m. Pacific Time / 11:15 a.m. Eastern Time. Interested parties may access a live and archived webcast ...

China has pressing reasons to make digital health care work: its rapidly ageing population will bring with it a wave of chronic diseases that the current system is ill-equipped to handle https://t.co/7qTs4Deu8k ...

Core Viewpoint - iRhythm Technologies, Inc. will release its financial results for Q3 2025 on October 30, 2025, after market close, followed by a conference call with management [1]. Company Overview - iRhythm Technologies is a leading digital health care company focused on creating solutions that detect, predict, and prevent disease [3]. - The company utilizes wearable biosensors and cloud-based data analytics combined with proprietary algorithms to transform data from millions of heartbeats into clinically actionable information [3]. - iRhythm's mission emphasizes improving patient care through better data, insights, and health outcomes [3]. Investor Information - Interested parties can access a live and archived webcast of the upcoming conference call on the company's investor website [2].

Core Viewpoint - iRhythm Technologies, Inc. will release its financial results for Q2 2025 on July 31, 2025, followed by a conference call to discuss the results [1] Company Overview - iRhythm Technologies is a leading digital health care company focused on creating solutions that detect, predict, and prevent disease [3] - The company utilizes wearable biosensors and cloud-based data analytics combined with proprietary algorithms to transform data from millions of heartbeats into clinically actionable information [3] - iRhythm aims to enhance patient care by providing better data, insights, and health outcomes [3] Conference Call Details - The conference call will begin at 1:30 p.m. PT / 4:30 p.m. ET on the same day as the financial results release [1] - Interested parties can access a live and archived webcast of the conference call on the company's investor website [2]

Core Viewpoint - iRhythm Technologies, Inc. is actively engaging with investors through scheduled presentations at multiple conferences, highlighting its commitment to transparency and investor relations [1][4]. Company Overview - iRhythm Technologies, Inc. is a leading digital health care company focused on creating solutions that detect, predict, and prevent disease [3]. - The company utilizes wearable biosensors and cloud-based data analytics combined with proprietary algorithms to transform data from millions of heartbeats into clinically actionable information [3]. - iRhythm's vision emphasizes improving patient care by delivering better data, insights, and health outcomes for all [3]. Upcoming Events - iRhythm is scheduled to present at the William Blair 45th Annual Growth Stock Conference on June 4, 2025, at 2:00 p.m. Central Time [4]. - The company will also participate in the Goldman Sachs 46th Annual Global Healthcare Conference on June 10, 2025, at 2:40 p.m. Eastern Time [4]. - Additionally, iRhythm will be featured at the Truist Securities MedTech Conference on June 17, 2025, at 1:40 p.m. Eastern Time [4].

Core Viewpoint - iRhythm Technologies, Inc. reported strong financial results for Q1 2025, with revenue growth exceeding 20% year-over-year, driven by increased demand for its Zio services and expansion into new markets, including Japan [3][4]. Financial Highlights - Revenue for Q1 2025 was $158.7 million, a 20.3% increase from $131.9 million in Q1 2024 [4][8]. - Gross profit for Q1 2025 was $109.2 million, up 24.8% from $87.5 million in Q1 2024, with a gross margin of 68.8%, an increase from 66.3% in the same period last year [5][8]. - Operating expenses for Q1 2025 were $141.8 million, compared to $125.7 million in Q1 2024, primarily due to funding innovation and serving a growing patient volume [6][8]. - The net loss for Q1 2025 was $30.7 million, or a diluted loss of $0.97 per share, an improvement from a net loss of $45.7 million, or a diluted loss of $1.47 per share, in Q1 2024 [7][8]. Operational Highlights - The company achieved a milestone of 10 million patient reports since its inception, indicating strong market penetration and demand for its services [3]. - iRhythm's recent commercial launch in Japan is part of its strategy to expand its global reach, now operating in six markets outside the U.S. [3][8]. - The company presented findings at ACC.25 showing that traditional Holter monitoring often misses actionable arrhythmias, highlighting the effectiveness of its Zio long-term continuous monitor [8]. Guidance and Future Outlook - iRhythm projects full-year 2025 revenue between $690 million to $700 million, with an adjusted EBITDA margin expected to range from approximately 7.5% to 8.5% [10][8]. - The company is optimistic about future growth driven by innovative value-based care accounts and increasing demand for Zio AT services in the U.S. and the U.K. [3][8].

Core Viewpoint - iRhythm Technologies, Inc. is actively participating in the Bank of America Securities 2025 Health Care Conference, showcasing its commitment to advancing digital health solutions [1][2]. Company Overview - iRhythm Technologies, Inc. is a leading digital health care company focused on creating solutions that detect, predict, and prevent disease through the use of wearable biosensors and cloud-based data analytics [3]. - The company utilizes proprietary algorithms to transform data from millions of heartbeats into clinically actionable information, aiming to enhance patient care and health outcomes [3]. Event Participation - iRhythm's management is scheduled to present at the conference on May 13, 2025, at 3:40 p.m. Pacific Time, with a live and archived webcast available for interested parties [2].

Core Viewpoint - iRhythm Technologies, Inc. will release its financial results for Q1 2025 on May 1, 2025, followed by a conference call to discuss the results [1]. Company Overview - iRhythm Technologies is a leading digital health care company focused on creating solutions that detect, predict, and prevent disease [3]. - The company utilizes wearable biosensors and cloud-based data analytics combined with proprietary algorithms to transform data from millions of heartbeats into clinically actionable information [3]. - iRhythm's vision emphasizes improving patient care through better data, insights, and health outcomes [3]. Conference Call Details - The conference call will begin at 1:30 p.m. PT / 4:30 p.m. ET on the same day as the financial results release [1]. - Interested parties can access a live and archived webcast of the conference call on the company's investor website [2].